Clarus appoints chief commercial officer
This article was originally published in Scrip
Executive Summary
Northbrook, Illinois-based Clarus Therapeutics, which specializes in men's health, has named Patrick Shea chief commercial officer. Prior to joining the company which is developing oral testosterone replacement product Rextoro, Mr Shea was vice-president of sales and marketing at CSL Behring (US operations). He will report directly to Clarus' president and CEO Dr Robert E Dudley.